TSH Variability of Patients Affected by Differentiated Thyroid Cancer Treated with Levothyroxine Liquid Solution or Tablet Form.
Carlo CappelliIlenia PirolaElena GandossiClaudio CasellaDavide LombardiBarbara AgostiFiorella MariniAndrea DelbarbaMaurizio CastellanoPublished in: International journal of endocrinology (2017)
The use of L-T4 liquid formulation, as compared to that of tablets, resulted in a significantly higher number of DTC patients maintaining TSH values in range for the ATA risk score, reducing TSH variability over the time.